Senior insider sale
AVALO THERAPEUTICS, INC. — senior position signals high conviction
$616.2K
42.83K shares
What this filing means
GOLDMAN JONATHAN plans to sell 42.83K shares of AVALO THERAPEUTICS, INC. valued at approximately $616.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/2/2026ACC: 0001950047-26-005476
42.83K
Shares to sell
$616.2K
Approx. market value
42.83K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months4
Exercise of options under a registered plan
Cash
6/2/2026
16.40KRestricted stock vesting under a registered plan
Services Rendered
6/2/2026
3.17KExercise of options under a registered plan
Cash
6/2/2026
20.10KRestricted stock vesting under a registered plan
Services Rendered
3/28/2026
3.17KTotal acquired42.83K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/2/2026 | Exercise of options under a registered plan Cash | 16.40K | — |
6/2/2026 | Restricted stock vesting under a registered plan Services Rendered | 3.17K | — |
6/2/2026 | Exercise of options under a registered plan Cash | 20.10K | — |
3/28/2026 | Restricted stock vesting under a registered plan Services Rendered | 3.17K | — |
| Total | 42.83K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
42.83K
Market value
$616.2K
6/2/2026
Total
Units
42.83K
Value
$616.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
6/2/2026 | 42.83K | $616.2K | NASDAQ | Planned |
| Total | 42.83K | $616.2K | ||